
Sign up to save your podcasts
Or
Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.
4.8
6262 ratings
Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.
1,271 Listeners
2,185 Listeners
1,014 Listeners
988 Listeners
1,774 Listeners
2,289 Listeners
3,981 Listeners
123 Listeners
317 Listeners
5,916 Listeners
1,544 Listeners
31 Listeners
146 Listeners
11 Listeners
45 Listeners